THE ROLE OF ASYMMETRIC DIMETHYLARGININE AS A PREDICTOR OF CARDIOVASCULAR DISEASES

dc.contributor.author	Makhkamova M.M., Nurillaeva N.M
dc.date.accessioned	2024-11-22T10:47:19Z
dc.date.available	2024-11-22T10:47:19Z
dc.date.issued	2024
dc.identifier.issn	2181-7812
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/204
dc.description.abstract	Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS), an enzyme responsible for producing nitric oxide (NO), a molecule with various cardiovascular protective effects including vasodilation and inhibition of platelet aggregation. Elevated levels of ADMA have been associated with endothelial dysfunction, inflammation, and oxidative stress, all of which are key factors in the development and progression of cardiovascular diseases (CVD).	en_US
dc.language.iso	en	en_US
dc.publisher	Вестник ТМА	en_US
dc.subject	Asymmetric dimethylarginine, cardiovascular disease, nitric oxide synthase, endothelial dysfunction, l-arginine.	en_US
dc.title	THE ROLE OF ASYMMETRIC DIMETHYLARGININE AS A PREDICTOR OF CARDIOVASCULAR DISEASES	en_US
dc.type	Article	en_US